Navigation Links
RNL BIO har anmält en fas II/III klinisk prövning till KFDA för en behandling av cerebral pares med autologa stamceller framställda från fettvävnad
Date:2/9/2013

SEOUL, Sydkorea, 9 feb. 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) annonserade idag att man har lämnat in en ansökan om ett nytt läkemedel under prövning (IND) till den sydkoreanska livsmedels- och läkemedelsmyndigheten (KFDA) med avsikt att inleda kliniska fas II och III-studier för att utvärdera företagets stamcellspreparat RNL-Astrostem™ hos patienter med cerebral pares. Syftet med studien är att slutgiltigt bedöma hur effektiva stamceller är som behandling av cerebral pares hos 45 patienter över 11 månader.  Studien kommer att genomföras på Kyung Hee universitetssjukhus i Gangdong och THE Bethesda-sjukhuset.

RNL-Astrostem™ har redan genomgått en fas I studie för att bekräfta säkerheten, inklusive tester för att utesluta toxicitet och tumorogenicitet.  Denna prövning genomfördes på Seoul National Universitys kliniska forskningsinstitut.  Dessutom bekräftade fas I-studien säkerheten hos stamceller som ges intravenöst, något som publicerats i en ledande referee-granskad tidskrift, Stem Cells and Development ("Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans", februari 2011). Under loppet av lyckade säkerhetsstudier fann forskarna signifikant evidens för att stamceller troligen kan vara effektiva vid behandling av cerebral pares. Dessutom publicerades en fallstudie med tydligt förbättrade resultat i en annan internationellt erkänd tidskrift. RNL BIO tror att man efter lyckade prövningar och godkännande från KFDA kommer att kunna lansera RNL-Astrostem™ år 2014, och därigenom revolutionera våra möjligheter att bota denna obotliga sjukdom som drabbar barn och som endast kan hanteras med befintlig behandling.

Ce
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
2. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
3. The Midwest Prepares to Tackle Gnats with an Unlikely Weapon
4. PAZOO Prepares For First Three National Direct Response Campaigns and Distribution of PAZOO Branded Products
5. MDHI Restocks Inventories - Prepares for Additional Retail Promotions With Americas Largest Discount Warehouse Chain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... company, is pleased to announce that it has engaged Mr ... Company,s business development capabilities in Japan and ... years of experience in business development, licensing and alliance management in ... Pharma ( Japan ), Nippon Roche and Tanabe Seiyaku ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... 2013  A recently published clinical study conducted at ... , demonstrates that 3D mammography (breast tomosynthesis) significantly ... The study, "Implementation of Breast Tomosynthesis in ... by Stephen L. Rose , MD, ... American Journal of Roentgenology (AJR). The AJR is ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... /PRNewswire-iReach/ -- CoLucid Pharmaceuticals, Inc., a ... has raised $7.5 million of a planned $9.5 ... to support further late stage development of lasmiditan.  ... Associates, Care Capital, Pearl Street Venture Funds and ...
... DIEGO, Aug. 30, 2011 aTyr Pharma , ... to aTyr,s leadership team of Dr. Jeffrey Greve, as ... president, intellectual property. Drs. Greve and Cubitt will support ... on Physiocrine biology. Physiocrines are naturally occurring human proteins ...
Cached Medicine Technology:CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 3
(Date:5/24/2013)... BestSatelliteProviders.com the online satellite TV and ... compare the features and services offered by leading ... the rankings of the best rural Internet ... on their website. , BestSatelliteProviders.com – ... Matthews, the spokesperson for BestSatelliteProviders.com, “When consumers were ...
(Date:5/24/2013)... According to the National Institutes of Health, Stevens Johnson Syndrome ... affects the skin and mucous membranes. SJS occurs most ... 30 (i). In the early stages SJS presents flu-like ... advances, it affects the mucous membranes such as the eyes, ... the eye causes conjunctivitis (pink eye). Inflammation of the ...
(Date:5/24/2013)... 24 (HealthDay News) -- The number of U.S. ... spending time in an emergency room has increased ... The study, conducted by researchers at the ... Health Services in Washington, D.C., found that patients ... average before being admitted to the ICU. The ...
(Date:5/24/2013)... Paris, France: A new investigational device - the Helio ... Sapien XT Transcatheter Heart Valve was successfully deployed in ... of its use in high-risk aortic insufficiency reported at ... an anchor to help stabilise the SAPIEN XT valve ... the heart are captured between the transcatheter heart valve ...
(Date:5/24/2013)... Coral Springs, FL (PRWEB) May 24, 2013 ... to present May air dates for Charlotte, North Carolina. It ... home to many Fortune 500 companies. The city is populated ... top-notch healthcare organizations which cover residents in both North and ... program about all things medically-related can tune into WAXN-TV 64 ...
Breaking Medicine News(10 mins):Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2
... for a new study has found that regular practice ... as well as the cognitive decline associated with ... practice, is centred on attentional and postural self-regulation and ... normal age-related decline of cerebral gray matter volume and ...
... nation towards climate change, India will propose a dedicated ... finance the development of clean energy technologies based ... ,In a position paper on climate change circulated ... it has in place comprehensive policy and legislative framework ...
... announced today that it has received marketing authorization from ... (adalimumab) as a treatment for severe Crohn's disease. HUMIRA ... Crohn's disease and offers an effective and convenient treatment ... of their disease. This announcement follows FDA approval for ...
... Doreen Granpeesheh, founder of the Center for Autism and ... Autism Society of America's highest honors -- the Wendy ... the Year -- at the organization's 38th annual national ... ,The award recognizes significant contributions made by a psychologist, ...
... University Medical drugs Center researchers have opened up a new ... to develop new drugs. ,The Duke researches ... involving human cells and rats. The drugs in question were ... the newer drug lapatinib, whose trade name is Tykerb. ...
... are in hospital with flu symptoms after an outbreak of ... minister said Friday. The five, aged between 11 months ... live within 300 metres (328 yards) of the outbreak -- ... outskirts of the capital. "They went to the hospital to ...
Cached Medicine News:Health News:India to Propose Global Fund for Clean Energy Technologies 2Health News:Abbott's Humira(r) (Adalimumab) Gets Approval by EU for Crohn's Disease Treatment 2Health News:Autism Society of America Gives Top Honor to Treatment Pioneer in Phoenix 2Health News:Breast Cancer Drug Curbs Heart Disease. 2Health News:Breast Cancer Drug Curbs Heart Disease. 3
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Used for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: